Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06780410

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Led by Gan & Lee Pharmaceuticals. · Updated on 2025-01-17

240

Participants Needed

1

Research Sites

40 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

CONDITIONS

Official Title

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years and older, male or female.
  • Body Mass Index (BMI) between 18 kg/m2 and 35 kg/m2.
  • Agreement to use reliable contraception from screening until 30 days after last dose and no donation of sperm or eggs for assisted reproduction.
  • Ability to understand study purpose and requirements, voluntary participation, and signing informed consent, with capability to complete the study.
Not Eligible

You will not qualify if you...

  • Allergy to any component of the investigational drug or history of allergic diseases such as asthma, urticaria, or eczema.
  • Fasting triglycerides levels equal or above 5.64 mmol/L (500 mg/dL) at screening.
  • History of malignant tumors before screening.
  • History of substance abuse including drugs, alcohol, or amphetamines.
  • Participation in other clinical trials or use of investigational drugs/devices within 3 months or 5 half-lives of drugs before screening.
  • Pregnant or breastfeeding females or positive pregnancy test.
  • Any other conditions deemed unsuitable by the investigator.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Site 01

Beijing, China

Actively Recruiting

Loading map...

Research Team

W

Wei Zhao

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here